Got Questions? Send us a message! We explore whether two old antiparasitics, fenbendazole and ivermectin, can meaningfully impact cancer by disrupting cell structure, metabolism, and immune signaling while challenging how drugs get approved and funded. We lay out the science, question the incentives, and call for trials that prioritize survival and quality of life. • Fenbendazole as a microtubule destabilizer leading to cell‑cycle arrest and apoptosis • Potential to bypass efflux pump resist...
All content for Fenben® Voices is the property of Fenbendazole Help and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Got Questions? Send us a message! We explore whether two old antiparasitics, fenbendazole and ivermectin, can meaningfully impact cancer by disrupting cell structure, metabolism, and immune signaling while challenging how drugs get approved and funded. We lay out the science, question the incentives, and call for trials that prioritize survival and quality of life. • Fenbendazole as a microtubule destabilizer leading to cell‑cycle arrest and apoptosis • Potential to bypass efflux pump resist...
S1EP7 Fenbendazole Unveiled: A Veterinary Staple's Leap into Cancer Research
Fenben® Voices
3 minutes
1 year ago
S1EP7 Fenbendazole Unveiled: A Veterinary Staple's Leap into Cancer Research
Got Questions? Send us a message!Join us on "Fenben Voices" for "Fenbendazole Unveiled: A Veterinary Staple's Leap into Cancer Research," an episode that traces the remarkable transformation of Fenbendazole from a widely used deworming agent to its emerging role in cancer therapy. This episode covers:Fenbendazole’s origins in veterinary medicine and its effectiveness against parasitic infections.The scientific awakening that expanded its potential beyond deworming to cancer treatment.Insights...
Fenben® Voices
Got Questions? Send us a message! We explore whether two old antiparasitics, fenbendazole and ivermectin, can meaningfully impact cancer by disrupting cell structure, metabolism, and immune signaling while challenging how drugs get approved and funded. We lay out the science, question the incentives, and call for trials that prioritize survival and quality of life. • Fenbendazole as a microtubule destabilizer leading to cell‑cycle arrest and apoptosis • Potential to bypass efflux pump resist...
